Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Catalano

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
BMC Public Health|February 26, 2009
Income inequality and alcohol attributable harm in AustraliaPaul M Dietze, Damien J Jolley, Tanya N Chikritzhs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology GroupStuart Hinton, Paul Catalano, Lawrence H Einhorn, et al.
Journal of Palliative Medicine|December 22, 2016
The Intensive Palliative Care Unit: Changing Outcomes for Hospitalized Cancer Patients in an Academic Medical CenterHaipeng Zhang, Constance Barysauskas, Elizabeth Rickerson, et al.
Australian and New Zealand Journal of Public Health|November 5, 2002
Towards a standardised methodology for estimating alcohol-caused death, injury and illness in AustraliaTanya Chikritzhs, Tim Stockwell, Helen Jonas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297Jordan D Berlin, Paul Catalano, James P Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sitesPatrick G Johnston, Al B Benson, Paul Catalano, et al.
Lung Cancer (Amsterdam, Netherlands)|November 19, 2011
Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancerMary E Cooley, Qian Wang, Bruce E Johnson, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 23, 2011
Minimizing image misregistration during PET/CT-guided percutaneous interventions with monitored breath-hold PET and CT acquisitionsPaul B Shyn, Servet Tatli, Nisha I Sainani, et al.
Clinical Colorectal Cancer|November 28, 2002
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancerJohn C Marsh, Paul Catalano, Jie Huang, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
BMC Public Health|February 26, 2009
Income inequality and alcohol attributable harm in AustraliaPaul M Dietze, Damien J Jolley, Tanya N Chikritzhs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology GroupStuart Hinton, Paul Catalano, Lawrence H Einhorn, et al.
Journal of Palliative Medicine|December 22, 2016
The Intensive Palliative Care Unit: Changing Outcomes for Hospitalized Cancer Patients in an Academic Medical CenterHaipeng Zhang, Constance Barysauskas, Elizabeth Rickerson, et al.
Australian and New Zealand Journal of Public Health|November 5, 2002
Towards a standardised methodology for estimating alcohol-caused death, injury and illness in AustraliaTanya Chikritzhs, Tim Stockwell, Helen Jonas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297Jordan D Berlin, Paul Catalano, James P Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sitesPatrick G Johnston, Al B Benson, Paul Catalano, et al.
Lung Cancer (Amsterdam, Netherlands)|November 19, 2011
Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancerMary E Cooley, Qian Wang, Bruce E Johnson, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 23, 2011
Minimizing image misregistration during PET/CT-guided percutaneous interventions with monitored breath-hold PET and CT acquisitionsPaul B Shyn, Servet Tatli, Nisha I Sainani, et al.
Clinical Colorectal Cancer|November 28, 2002
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancerJohn C Marsh, Paul Catalano, Jie Huang, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Pageof 6